INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹3.31 Cr | ₹-6.53 Cr | ₹8.05 Cr | ₹-14 Cr | ₹2.97 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDOCO REMEDIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹3.31 Cr |
Mar2023 | ₹-6.53 Cr |
Mar2022 | ₹8.05 Cr |
Mar2021 | ₹-14 Cr |
Mar2020 | ₹2.97 Cr |
How is Net Cash Inflow / Outflow of INDOCO REMEDIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹3.31 Cr | Positive | |
Mar2023 | ₹-6.53 Cr | Negative | |
Mar2022 | ₹8.05 Cr | Positive | |
Mar2021 | ₹-14 Cr | Negative | |
Mar2020 | ₹2.97 Cr | - |
Compare Net Cash Inflow / Outflow of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,222.9 Cr | 1.5% | -2.7% | -28.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 1.5% |
-2.7% |
-28.1% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses